Menu
GeneBe

rs34504623

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004168.4(SDHA):c.1908+15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.105 in 1,540,732 control chromosomes in the GnomAD database, including 9,916 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.079 ( 680 hom., cov: 28)
Exomes 𝑓: 0.11 ( 9236 hom. )

Consequence

SDHA
NM_004168.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.98
Variant links:
Genes affected
SDHA (HGNC:10680): (succinate dehydrogenase complex flavoprotein subunit A) This gene encodes a major catalytic subunit of succinate-ubiquinone oxidoreductase, a complex of the mitochondrial respiratory chain. The complex is composed of four nuclear-encoded subunits and is localized in the mitochondrial inner membrane. Mutations in this gene have been associated with a form of mitochondrial respiratory chain deficiency known as Leigh Syndrome. A pseudogene has been identified on chromosome 3q29. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 5-254521-C-T is Benign according to our data. Variant chr5-254521-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 259245.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-254521-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.117 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SDHANM_004168.4 linkuse as main transcriptc.1908+15C>T intron_variant ENST00000264932.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SDHAENST00000264932.11 linkuse as main transcriptc.1908+15C>T intron_variant 1 NM_004168.4 P1P31040-1

Frequencies

GnomAD3 genomes
AF:
0.0791
AC:
11899
AN:
150508
Hom.:
680
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0214
Gnomad AMI
AF:
0.0706
Gnomad AMR
AF:
0.0692
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.00156
Gnomad SAS
AF:
0.0159
Gnomad FIN
AF:
0.114
Gnomad MID
AF:
0.0318
Gnomad NFE
AF:
0.119
Gnomad OTH
AF:
0.0822
GnomAD3 exomes
AF:
0.0783
AC:
12239
AN:
156268
Hom.:
644
AF XY:
0.0766
AC XY:
6343
AN XY:
82858
show subpopulations
Gnomad AFR exome
AF:
0.0163
Gnomad AMR exome
AF:
0.0601
Gnomad ASJ exome
AF:
0.0962
Gnomad EAS exome
AF:
0.000176
Gnomad SAS exome
AF:
0.0151
Gnomad FIN exome
AF:
0.120
Gnomad NFE exome
AF:
0.117
Gnomad OTH exome
AF:
0.0977
GnomAD4 exome
AF:
0.108
AC:
150186
AN:
1390108
Hom.:
9236
Cov.:
31
AF XY:
0.105
AC XY:
72411
AN XY:
686536
show subpopulations
Gnomad4 AFR exome
AF:
0.0176
Gnomad4 AMR exome
AF:
0.0643
Gnomad4 ASJ exome
AF:
0.100
Gnomad4 EAS exome
AF:
0.000139
Gnomad4 SAS exome
AF:
0.0167
Gnomad4 FIN exome
AF:
0.127
Gnomad4 NFE exome
AF:
0.122
Gnomad4 OTH exome
AF:
0.0999
GnomAD4 genome
AF:
0.0790
AC:
11895
AN:
150624
Hom.:
680
Cov.:
28
AF XY:
0.0762
AC XY:
5605
AN XY:
73572
show subpopulations
Gnomad4 AFR
AF:
0.0213
Gnomad4 AMR
AF:
0.0691
Gnomad4 ASJ
AF:
0.103
Gnomad4 EAS
AF:
0.00157
Gnomad4 SAS
AF:
0.0157
Gnomad4 FIN
AF:
0.114
Gnomad4 NFE
AF:
0.119
Gnomad4 OTH
AF:
0.0813
Alfa
AF:
0.0938
Hom.:
125
Bravo
AF:
0.0746

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxDec 02, 2015This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Mitochondrial complex II deficiency, nuclear type 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Leigh syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 31, 2019- -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 14, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Paragangliomas 5 Benign:1
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Hereditary pheochromocytoma-paraganglioma Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
Cadd
Benign
0.086
Dann
Benign
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34504623; hg19: chr5-254636; COSMIC: COSV53767694; COSMIC: COSV53767694; API